Macheret F, Heublein D, Costello-Boerrigter LC, Boerrigter G, McKie P, Bellavia D, Mangiafico S, Ikeda Y, Bailey K, Scott CG, Sandberg S, Chen HH, Malatino L, Redfield MM, Rodeheffer R, Burnett J, Cataliotti A (2012)
Human hypertension is characterized by a lack of activation of the antihypertensive cardiac hormones ANP and BNP
J Am Coll Cardiol, 60 (16), 1558-65
PubMed
23058313 DOI
10.1016/j.jacc.2012.05.049
Mangiafico S, Costello-Boerrigter LC, Andersen IA, Cataliotti A, Burnett JC (2012)
Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics
Eur Heart J, 34 (12), 886-893c
PubMed
22942338 DOI
10.1093/eurheartj/ehs262
Malatino LS, Cataliotti A, Stancanelli B, Zoccali C (2012)
Hepatocyte growth factor and cardiomyopathy in dialysis patients
Hypertension, 60 (3), e24; author reply e25-6
PubMed
22868387 DOI
10.1161/HYPERTENSIONAHA.112.198424
Cataliotti A, Costello-Boerrigter LC, Chen HH, Textor SC, Burnett JC (2012)
Sustained blood pressure-lowering actions of subcutaneous B-type natriuretic peptide (nesiritide) in a patient with uncontrolled hypertension
Mayo Clin Proc, 87 (4), 413-5
PubMed
22469356 DOI
10.1016/j.mayocp.2012.02.003
McKie PM, Cataliotti A, Sangaralingham SJ, Ichiki T, Cannone V, Bailey KR, Redfield MM, Rodeheffer RJ, Burnett JC (2011)
Predictive utility of atrial, N-terminal pro-atrial, and N-terminal pro-B-type natriuretic peptides for mortality and cardiovascular events in the general community: a 9-year follow-up study
Mayo Clin Proc, 86 (12), 1154-60
PubMed
22134933 DOI
10.4065/mcp.2011.0437
Martin FL, McKie PM, Cataliotti A, Sangaralingham SJ, Korinek J, Huntley BK, Oehler EA, Harders GE, Ichiki T, Mangiafico S, Nath KA, Redfield MM, Chen HH, Burnett JC (2011)
Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: a kidney-heart connection
Am J Physiol Regul Integr Comp Physiol, 302 (2), R292-9
PubMed
22071162 DOI
10.1152/ajpregu.00194.2011
Sangaralingham SJ, Heublein DM, Grande JP, Cataliotti A, Rule AD, McKie PM, Martin FL, Burnett JC (2011)
Urinary C-type natriuretic peptide excretion: a potential novel biomarker for renal fibrosis during aging
Am J Physiol Renal Physiol, 301 (5), F943-52
PubMed
21865266 DOI
10.1152/ajprenal.00170.2011
Cannone V, Boerrigter G, Cataliotti A, Costello-Boerrigter LC, Olson TM, McKie PM, Heublein DM, Lahr BD, Bailey KR, Averna M, Redfield MM, Rodeheffer RJ, Burnett JC (2011)
A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community
J Am Coll Cardiol, 58 (6), 629-36
PubMed
21798427 DOI
10.1016/j.jacc.2011.05.011
Tonne JM, Campbell JM, Cataliotti A, Ohmine S, Thatava T, Sakuma T, Macheret F, Huntley BK, Burnett JC, Ikeda Y (2011)
Secretion of glycosylated pro-B-type natriuretic peptide from normal cardiomyocytes
Clin Chem, 57 (6), 864-73
PubMed
21482747 DOI
10.1373/clinchem.2010.157438
Macheret F, Boerrigter G, McKie P, Costello-Boerrigter L, Lahr B, Heublein D, Sandberg S, Ikeda Y, Cataliotti A, Bailey K, Rodeheffer R, Burnett JC (2011)
Pro-B-type natriuretic peptide(1-108) circulates in the general community: plasma determinants and detection of left ventricular dysfunction
J Am Coll Cardiol, 57 (12), 1386-95
PubMed
21414536 DOI
10.1016/j.jacc.2011.01.005